Literature DB >> 20156529

Localization of dopamine- and cAMP-regulated phosphoprotein-32 and inhibitor-1 in area 9 of Macaca mulatta prefrontal cortex.

J R Glausier1, M Maddox, H C Hemmings, A C Nairn, P Greengard, E C Muly.   

Abstract

The actions of dopamine D1 family receptors (D1R) depend upon a signal transduction cascade that modulates the phosphorylation state of important effector proteins, such as glutamate receptors and ion channels. This is accomplished both through activation of protein kinase A (PKA) and the inhibition of protein phosphatase-1 (PP1). Inhibition of PP1 occurs through PKA-mediated phosphorylation of dopamine- and cAMP-regulated phosphoprotein 32 kDa (DARPP-32) or the related protein inhibitor-1 (I-1), and the availability of DARPP-32 is essential to the functional outcome of D1R activation in the basal ganglia. While D1R activation is critical for prefrontal cortex (PFC) function, especially working memory, the functional role played by DARPP-32 or I-1 is less clear. In order to examine this more thoroughly, we have utilized immunoelectron microscopy to quantitatively determine the localization of DARPP-32 and I-1 in the neuropil of the rhesus monkey PFC. Both were distributed widely in the different components of the neuropil, but were enriched in dendritic shafts. I-1 label was more frequently identified in axon terminals than was DARPP-32, and DARPP-32 label was more frequently identified in glia than was I-1. We also quantified the extent to which these proteins were found in dendritic spines. DARPP-32 and I-1 were present in small subpopulations of dendritic spines, (4.4% and 7.7% and respectively), which were substantially smaller than observed for D1R in our previous studies (20%). Double-label experiments did not find evidence for colocalization of D1R and DARPP-32 or I-1 in spines or terminals. Thus, at the least, not all prefrontal spines which contain D1R also contain I-1 or DARPP-32, suggesting important differences in D1R signaling in the PFC compared to the striatum. (c) 2010 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20156529      PMCID: PMC2863358          DOI: 10.1016/j.neuroscience.2010.02.014

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  71 in total

1.  Subcellular distribution of spinophilin immunolabeling in primate prefrontal cortex: localization to and within dendritic spines.

Authors:  E Chris Muly; Yoland Smith; Patrick Allen; Paul Greengard
Journal:  J Comp Neurol       Date:  2004-02-02       Impact factor: 3.215

2.  Distribution of mGluR1alpha and mGluR5 immunolabeling in primate prefrontal cortex.

Authors:  E Chris Muly; Marcelia Maddox; Yoland Smith
Journal:  J Comp Neurol       Date:  2003-12-22       Impact factor: 3.215

3.  Potentiation of NMDA receptor currents by dopamine D1 receptors in prefrontal cortex.

Authors:  Guojun Chen; Paul Greengard; Zhen Yan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

4.  Dopamine D1-class receptors selectively modulate a slowly inactivating potassium current in rat medial prefrontal cortex pyramidal neurons.

Authors:  Yan Dong; Francis J White
Journal:  J Neurosci       Date:  2003-04-01       Impact factor: 6.167

Review 5.  The principal features and mechanisms of dopamine modulation in the prefrontal cortex.

Authors:  Jeremy K Seamans; Charles R Yang
Journal:  Prog Neurobiol       Date:  2004-09       Impact factor: 11.685

6.  Intra-medial prefrontal administration of SCH-23390 attenuates ERK phosphorylation and long-term memory for trace fear conditioning in rats.

Authors:  Jason D Runyan; Pramod K Dash
Journal:  Neurobiol Learn Mem       Date:  2004-09       Impact factor: 2.877

7.  Separation and characterization of two phosphorylase phosphatase inhibitors from rabbit skeletal muscle.

Authors:  F L Huang; W H Glinsmann
Journal:  Eur J Biochem       Date:  1976-11-15

8.  GABAA receptor phospho-dependent modulation is regulated by phospholipase C-related inactive protein type 1, a novel protein phosphatase 1 anchoring protein.

Authors:  Miho Terunuma; Il-Sung Jang; Sang Hoon Ha; Josef T Kittler; Takashi Kanematsu; Jasmina N Jovanovic; Keiichi I Nakayama; Norio Akaike; Sung Ho Ryu; Stephen J Moss; Masato Hirata
Journal:  J Neurosci       Date:  2004-08-11       Impact factor: 6.167

9.  Protein phosphatase 1 is a molecular constraint on learning and memory.

Authors:  David Genoux; Ursula Haditsch; Marlen Knobloch; Aubin Michalon; Daniel Storm; Isabelle M Mansuy
Journal:  Nature       Date:  2002-08-29       Impact factor: 49.962

10.  Dopamine receptor-mediated Ca(2+) signaling in striatal medium spiny neurons.

Authors:  Tie-Shan Tang; Ilya Bezprozvanny
Journal:  J Biol Chem       Date:  2004-08-02       Impact factor: 5.157

View more
  4 in total

1.  An essential role for inhibitor-2 regulation of protein phosphatase-1 in synaptic scaling.

Authors:  Benjamin A Siddoway; Haider F Altimimi; Hailong Hou; Ronald S Petralia; Bo Xu; David Stellwagen; Houhui Xia
Journal:  J Neurosci       Date:  2013-07-03       Impact factor: 6.167

2.  Beyond the dopamine receptor: regulation and roles of serine/threonine protein phosphatases.

Authors:  Sven Ivar Walaas; Hugh Caroll Hemmings; Paul Greengard; Angus Clark Nairn
Journal:  Front Neuroanat       Date:  2011-08-26       Impact factor: 3.856

3.  Spatial distribution of DARPP-32 in dendritic spines.

Authors:  Hans Blom; Daniel Rönnlund; Lena Scott; Linda Westin; Jerker Widengren; Anita Aperia; Hjalmar Brismar
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

4.  Synaptic NMDA receptor stimulation activates PP1 by inhibiting its phosphorylation by Cdk5.

Authors:  Hailong Hou; Lu Sun; Benjamin A Siddoway; Ronald S Petralia; Hongtian Yang; Hua Gu; Angus C Nairn; Houhui Xia
Journal:  J Cell Biol       Date:  2013-11-04       Impact factor: 10.539

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.